AlzChem Group AG (XTER:ACT) Research & Development : €0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is AlzChem Group AG Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. AlzChem Group AG's Research & Development for the three months ended in Mar. 2024 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0.0 Mil.

AlzChem Group AG Research & Development Historical Data

The historical data trend for AlzChem Group AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzChem Group AG Research & Development Chart

AlzChem Group AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

AlzChem Group AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

AlzChem Group AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

AlzChem Group AG (XTER:ACT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

AlzChem Group AG Research & Development Related Terms

Thank you for viewing the detailed overview of AlzChem Group AG's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

AlzChem Group AG (XTER:ACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » AlzChem Group AG (XTER:ACT) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

SFP1:Germany ACT:Germany

Address

Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308

Website

https://www.alzchem.com

AlzChem Group AG is an international chemical company. Its reportable segments are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.